The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126051831 12605183 1 I 20110810 20111012 20160729 20160729 EXP US-ROCHE-1004074 ROCHE 69.00 YR M Y 76.70000 KG 20160729 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126051831 12605183 1 PS Vismodegib VISMODEGIB 1 Oral 21 DAYS CYCLE?LAST DOSE ADMINISTERED: 14/SEP/2011 AND 15-NOV-2011 203388 2850 MG CAPSULE QD
126051831 12605183 2 SS Vismodegib VISMODEGIB 1 Oral 203388 4050 MG CAPSULE
126051831 12605183 3 SS Vismodegib VISMODEGIB 1 Oral 203388 4050 MG CAPSULE
126051831 12605183 4 SS Vismodegib VISMODEGIB 1 Oral 203388 4200 MG CAPSULE
126051831 12605183 5 SS Vismodegib VISMODEGIB 1 Oral 15/NOV/2011 203388 3150 MG CAPSULE
126051831 12605183 6 SS Vismodegib VISMODEGIB 1 Oral 203388 3000 MG CAPSULE
126051831 12605183 7 SS ETOPOSIDE. ETOPOSIDE 1 Intravenous (not otherwise specified) OVER 2 HRS ON DAY 1-3?LAST DATE ADMINISTERED: 02/SEP/2011 AND 28-OCT-2011, DOSE DELAYED BY 7 DAYS 0
126051831 12605183 8 SS CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) OVER 2 HRS ON DAY 1?LAST DATE ADMINISTERED: 31/AUG/2011 AND 26-OCT-2011, DOSE DELAYED BY 7 DAYS. 0 75 MG/M**2
126051831 12605183 9 C ATENOLOL. ATENOLOL 1 Oral QD 0 100 MG
126051831 12605183 10 C LISINOPRIL. LISINOPRIL 1 Oral QD 0 40 MG
126051831 12605183 11 C RISPERIDONE. RISPERIDONE 1 Oral QD 0 4 MG
126051831 12605183 12 C VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Oral QD 0 150 MG
126051831 12605183 13 C OMEPRAZON OMEPRAZOLE 1 Oral 0 20 MG QID
126051831 12605183 14 C OXYBUTYNIN OXYBUTYNIN 1 Oral 0 5 MG BID
126051831 12605183 15 C PRAZOSIN PRAZOSIN 1 Oral 0 5 MG BID
126051831 12605183 16 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral QD 0 5 MG
126051831 12605183 17 C APREPITANT. APREPITANT 1 Oral 125MG DAY 1, AND 80MG DAY 2 AND 3 0
126051831 12605183 18 C OXYCODONE OXYCODONE 1 Oral 0 5 MG Q4H

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126051831 12605183 1 Small cell lung cancer
126051831 12605183 7 Small cell lung cancer
126051831 12605183 8 Small cell lung cancer

Outcome of event

Event ID CASEID OUTC COD
126051831 12605183 HO
126051831 12605183 OT
126051831 12605183 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126051831 12605183 Acidosis
126051831 12605183 Delirium
126051831 12605183 Dyspnoea
126051831 12605183 Hypertension
126051831 12605183 Neutrophil count decreased
126051831 12605183 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126051831 12605183 1 20110810 0
126051831 12605183 2 20110831 0
126051831 12605183 3 20110831 0
126051831 12605183 4 20110928 0
126051831 12605183 5 20111026 0
126051831 12605183 6 20111207 0
126051831 12605183 7 20110810 0
126051831 12605183 8 20110810 0